Stock Scorer

Elite Health Systems Inc. (EHSI)

Elite Health Systems Inc. reported revenue of 1.3M USD for the quarter ending 30 June 2026.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.3M —
Gross Profit Q2 '26 · ending 30 June 2026 168K —
Operating Income Q2 '26 · ending 30 June 2026 -1.5M —
Net Income Q2 '26 · ending 30 June 2026 -1.5M —
Cost of Revenue Q2 '26 · ending 30 June 2026 1.1M —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -1.4M —
Shares Outstanding Q2 '26 · ending 30 June 2026 28.5M +35.3%
EPS Q2 '26 · ending 30 June 2026 -0.41 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1M-3.8M-7.8M-2.9M
20242024-12-31 0-1.8M-2.1M-1.5M
20232023-12-31 0-765K-816K—
20222022-12-31 0-1.4M-1.3M—
20212021-12-31 1.1M-88K-881K—
20202020-12-31 3.2M1.6M533K—
20192019-12-31 3.1M1.5M142K—
20182018-12-31 3.4M131K-421K—
20172017-12-31 3.4M688K538K—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.3M
Q1 '262026-03-311.4M
Q4 '252025-12-311M
Q3 '252025-09-300
Q2 '252025-06-300
Q1 '252025-03-310
Q4 '242024-12-310
Q3 '242024-09-300
Q2 '242024-06-300
Q1 '242024-03-310
Q4 '232023-12-310
Q3 '232023-09-300
Q2 '232023-06-300
Q1 '232023-03-310
Q4 '222022-12-310
Q3 '222022-09-300
Q2 '222022-06-300
Q1 '222022-03-310
Q4 '212021-12-310
Q3 '212021-09-300

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30168K
Q1 '262026-03-31117K
Q2 '252025-06-300

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-1.5M
Q1 '262026-03-31-1.3M
Q4 '252025-12-31-1.8M
Q3 '252025-09-30-1.2M
Q2 '252025-06-30-445K
Q1 '252025-03-31-427K
Q4 '242024-12-31-494K
Q3 '242024-09-30-387K
Q2 '242024-06-30-437K
Q1 '242024-03-31-476K
Q4 '232023-12-31-243K
Q3 '232023-09-30-151K
Q2 '232023-06-30-242K
Q1 '232023-03-31-130K
Q4 '222022-12-31-508K
Q3 '222022-09-30-221K
Q2 '222022-06-30-292K
Q1 '222022-03-31-360K
Q4 '212021-12-31-248K
Q3 '212021-09-30-268K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-1.5M
Q1 '262026-03-31-1.3M
Q4 '252025-12-31-5.8M
Q3 '252025-09-30-1.2M
Q2 '252025-06-30-441K
Q1 '252025-03-31-424K
Q4 '242024-12-31-1M
Q3 '242024-09-30-290K
Q2 '242024-06-30-432K
Q1 '242024-03-31-312K
Q4 '232023-12-31-146K
Q3 '232023-09-30-127K
Q2 '232023-06-30-434K
Q1 '232023-03-31-108K
Q4 '222022-12-31502K
Q3 '222022-09-30-321K
Q2 '222022-06-30-1.1M
Q1 '222022-03-31-421K
Q4 '212021-12-31-204K
Q3 '212021-09-30-352K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-301.1M
Q1 '262026-03-311.3M
Q2 '252025-06-300
Q1 '252025-03-310

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-1.4M
Q1 '262026-03-31-1.3M
Q4 '252025-12-31-1.5M
Q3 '252025-09-30-817K
Q2 '252025-06-30-334K
Q1 '252025-03-31-297K
Q4 '242024-12-31-527K
Q3 '242024-09-30-72K
Q2 '242024-06-30-455K
Q1 '242024-03-31-461K
Q4 '232023-12-31-320K
Q3 '232023-09-30177K
Q2 '232023-06-30-618K
Q1 '232023-03-31-130K
Q4 '222022-12-31-272K
Q3 '222022-09-30-234K
Q2 '222022-06-30-571K
Q1 '222022-03-31-336K
Q4 '212021-12-31-268K
Q3 '212021-09-30-193K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3028.5M
Q1 '262026-03-3128.5M
Q3 '252025-09-3021.7M
Q2 '252025-06-3021.4M
Q1 '252025-03-3121.1M
Q3 '242024-09-3017M
Q2 '242024-06-3013.5M
Q1 '242024-03-3111.9M
Q3 '232023-09-307.9M
Q2 '232023-06-307.9M
Q1 '232023-03-317.8M
Q3 '222022-09-307.8M
Q2 '222022-06-307.8M
Q1 '222022-03-317.8M
Q3 '212021-09-307.8M
Q2 '212021-06-307.8M
Q1 '212021-03-317.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.41
Q1 '262026-03-31-0.38
Q4 '252025-12-31-0.35
Q3 '252025-09-30-0.14
Q2 '252025-06-30-0.11
Q1 '252025-03-31-0.12
Q4 '242024-12-31-0.13
Q3 '242024-09-30-0.17
Q2 '242024-06-30-0.17
Q1 '242024-03-31-0.19
Q4 '232023-12-31-0.17
Q3 '232023-09-30-0.02
Q2 '232023-06-30-0.04
Q1 '232023-03-31-0.13
Q4 '222022-12-31-0.17
Q3 '222022-09-30-0.26
Q2 '222022-06-30-0.27
Q1 '222022-03-31-0.21
Q4 '212021-12-31-0.12
Q3 '212021-09-30-0.07